Pierluigi Viale

25.0k total citations · 2 hit papers
419 papers, 10.1k citations indexed

About

Pierluigi Viale is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Pierluigi Viale has authored 419 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 183 papers in Epidemiology, 180 papers in Infectious Diseases and 113 papers in Pharmacology. Recurrent topics in Pierluigi Viale's work include Antibiotics Pharmacokinetics and Efficacy (112 papers), Antibiotic Resistance in Bacteria (99 papers) and Antibiotic Use and Resistance (64 papers). Pierluigi Viale is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (112 papers), Antibiotic Resistance in Bacteria (99 papers) and Antibiotic Use and Resistance (64 papers). Pierluigi Viale collaborates with scholars based in Italy, United States and Spain. Pierluigi Viale's co-authors include Federico Pea, Maddalena Giannella, Mario Furlanut, Michele Bartoletti, Sara Tedeschi, Francesco Cristini, Simone Ambretti, Russell E. Lewis, Matteo Bassetti and Pier Giorgio Cojutti and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Pierluigi Viale

400 papers receiving 9.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy

2012 744 citations Mario Tumbarello, Pierluigi Viale et al. profile →
Infections caused by KPC-producing Klebsiella pneumoniae : differences in therapy and mortality in a multicentre study

2015 395 citations Mario Tumbarello, Enrico Maria Trecarichi et al. Journal of Antimicrobial Chemotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pierluigi Viale Italy	49	3.7k	3.4k	3.3k	3.2k	1.7k	419	10.1k
Andrew F. Shorr United States	73	6.3k 1.7×	3.9k 1.2×	2.4k 0.7×	1.8k 0.6×	2.0k 1.1×	345	15.9k
Scott T. Micek United States	51	4.8k 1.3×	2.4k 0.7×	1.8k 0.5×	1.4k 0.4×	1.9k 1.1×	174	9.1k
José Garnacho‐Montero Spain	53	4.7k 1.2×	2.6k 0.8×	2.4k 0.7×	1.6k 0.5×	1.8k 1.0×	189	9.4k
Mical Paul Israel	70	6.4k 1.7×	3.4k 1.0×	3.8k 1.1×	3.0k 0.9×	2.3k 1.3×	320	16.3k
Ebbing Lautenbach United States	53	3.6k 1.0×	2.3k 0.7×	3.4k 1.0×	1.8k 0.6×	2.5k 1.4×	291	9.7k
Roberto Cauda Italy	53	4.0k 1.1×	5.5k 1.6×	2.7k 0.8×	1.3k 0.4×	1.5k 0.9×	330	12.2k
Mario Venditti Italy	54	4.3k 1.2×	3.8k 1.1×	2.2k 0.6×	1.2k 0.4×	989 0.6×	281	9.7k
Jordi Carratalà Spain	63	8.6k 2.3×	2.8k 0.8×	2.3k 0.7×	1.5k 0.5×	1.2k 0.7×	332	14.2k
Federico Pea Italy	44	2.5k 0.7×	2.3k 0.7×	1.9k 0.6×	4.5k 1.4×	1.2k 0.7×	278	7.5k
Winfried V. Kern Germany	55	3.1k 0.8×	3.0k 0.9×	2.6k 0.8×	1.4k 0.5×	918 0.5×	289	10.1k

Countries citing papers authored by Pierluigi Viale

Since Specialization

Citations

This map shows the geographic impact of Pierluigi Viale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierluigi Viale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierluigi Viale more than expected).

Fields of papers citing papers by Pierluigi Viale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierluigi Viale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierluigi Viale. The network helps show where Pierluigi Viale may publish in the future.

Co-authorship network of co-authors of Pierluigi Viale

This figure shows the co-authorship network connecting the top 25 collaborators of Pierluigi Viale. A scholar is included among the top collaborators of Pierluigi Viale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierluigi Viale. Pierluigi Viale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yücel, Emre, Àlex Soriano, David L. Paterson, et al.. (2025). Real-world analysis of ceftolozane/tazobactam prescribing patterns and effectiveness: SPECTRA analysis on chronic pulmonary diseases and respiratory-related infections. Journal of Global Antimicrobial Resistance. 44. 217–225.

Gatti, Milo, Matteo Rinaldi, Cristiana Laici, et al.. (2025). Highly adsorptive removal of cefiderocol during continuous venovenous hemodiafiltration equipped with oXiris filter in an orthotopic liver transplant recipient having septic shock caused by VIM-producing Klebsiella pneumoniae. Journal of Antimicrobial Chemotherapy. 80(4). 1153–1155. 2 indexed citations

Zamparini, Eleonora, et al.. (2025). Methicillin-resistant Staphylococcus epidermidis knee prosthetic infection treatment with two-stage revision and fosfomycin–rifampin combination therapy: a case report. Journal of Medical Case Reports. 19(1). 55–55.

Soriano, Àlex, David L. Paterson, Stefan Kluge, et al.. (2025). A real-world investigation into prescribing patterns and effectiveness of ceftolozane/tazobactam among critically ill patients from SPECTRA. Diagnostic Microbiology and Infectious Disease. 111(4). 116737–116737.

Soriano, Àlex, David L. Paterson, Florian Thalhammer, et al.. (2025). Unveiling results and insights from multinational, multicenter Study of Prescribing patterns and Effectiveness of Ceftolozane/Tazobactam Real-world Analysis (SPECTRA). Journal of Global Antimicrobial Resistance. 41. 272–279. 3 indexed citations

Gatti, Milo, Matteo Rinaldi, Tommaso Tonetti, et al.. (2024). Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP. Antibiotics. 13(4). 296–296. 2 indexed citations

Bonazzetti, Cecilia, Matteo Rinaldi, Federica Cosentino, et al.. (2024). Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with “difficult to treat” Gram‐negative bacteria. Transplant Infectious Disease. 26(2). 2 indexed citations

Cojutti, Pier Giorgio, Matteo Rinaldi, Tommaso Tonetti, et al.. (2024). Impact of Continuous Infusion Meropenem PK/PD Target Attainment on C-Reactive Protein Dynamics in Critically Ill Patients With Documented Gram-Negative Hospital-Acquired or Ventilator-Associated Pneumonia. Clinical Pharmacokinetics. 63(11). 1573–1583. 1 indexed citations

Maietti, Elisa, Erik Bertoletti, Filippo Trapani, et al.. (2023). Healthcare-associated infections and antimicrobial resistance in severe acquired brain injury: a retrospective multicenter study. Frontiers in Neurology. 14. 1219862–1219862. 3 indexed citations

10.

Gatti, Milo, Vincent H. Tam, Paolo Gaibani, et al.. (2023). A novel method to evaluate ceftazidime/avibactam therapy in patients with carbapenemase-producing Enterobactericeae (CPE) bloodstream infections. International Journal of Antimicrobial Agents. 61(4). 106760–106760. 9 indexed citations

11.

Cojutti, Pier Giorgio, Milo Gatti, Nieko Punt, et al.. (2023). Implementation and validation of a Bayesian method for accurately forecasting duration of optimal pharmacodynamic target attainment with dalbavancin during long-term use for subacute and chronic staphylococcal infections. International Journal of Antimicrobial Agents. 63(1). 107038–107038. 9 indexed citations

12.

Fiore, Michele, Andrea Sambri, Matteo Filippini, et al.. (2022). Are Static Spacers Superior to Articulated Spacers in the Staged Treatment of Infected Primary Knee Arthroplasty? A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 11(16). 4854–4854. 9 indexed citations

13.

Viciani, Elisa, Paolo Gaibani, Andrea Castagnetti, et al.. (2022). Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in patients colonized with Candida spp.. International Journal of Infectious Diseases. 117. 233–240. 14 indexed citations

14.

Gaibani, Paolo, Donatella Lombardo, Linda Bussini, et al.. (2021). Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018. Antibiotics. 10(5). 536–536. 38 indexed citations

15.

Privitera, Gaetano Pierpaolo, Anna Laura Costa, Silvio Brusaferro, et al.. (2016). Skin antisepsis with chlorhexidine versus iodine for the prevention of surgical site infection: A systematic review and meta-analysis. American Journal of Infection Control. 45(2). 180–189. 78 indexed citations

16.

Fiorino, Sirio, Elisabetta Loggi, Gabriella Verucchi, et al.. (2016). Vitamin E for the treatment of E‐antigen‐positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study. Liver International. 37(1). 54–61. 6 indexed citations

17.

Calza, Leonardo, Vincenzo Colangeli, Isabella Bon, et al.. (2016). Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy. AIDS Research and Human Retroviruses. 33(2). 126–132. 15 indexed citations

18.

Tumbarello, Mario, Enrico Maria Trecarichi, Francesco Giuseppe De Rosa, et al.. (2015). Infections caused by KPC-producing Klebsiella pneumoniae : differences in therapy and mortality in a multicentre study. Journal of Antimicrobial Chemotherapy. 70(7). 2133–2143. 395 indexed citations breakdown →

19.

Girometti, Nicolò, Russell E. Lewis, Maddalena Giannella, et al.. (2014). Klebsiella pneumoniae Bloodstream Infection. Medicine. 93(17). 298–309. 90 indexed citations

20.

Nanni, Cristina, Luca Boriani, Caterina Salvadori, et al.. (2012). FDG PET/CT is useful for the interim evaluation of response to therapy in patients affected by haematogenous spondylodiscitis. European Journal of Nuclear Medicine and Molecular Imaging. 39(10). 1538–1544. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact